Skip to content

Medical emergency? What to do

Lipid-lowering drug delays diabetes in the obese

3-RXPublished November 3, 20052 min read

Key points

  • Treatment with bezafibrate to lower cholesterol curbs the incidence and delays the onset of type 2 diabetes in obese individuals, doctors in Israel report.
  • "Our study," he continued, "has shown that bezafibrate can reduce the incidence of type 2 diabetes with a magnitude of benefit even better than other medications -- 41 percent reduction during about 6 years.
  • In an earlier study, the researchers observed that bezafibrate reduced the incidence of diabetes in patients with impaired fasting glucose levels, a precursor to full-blown diabetes.
  • Moreover, the time to onset of diabetes was significantly longer in the bezafibrate group compared with the placebo group -- 4 years versus 2 years.

Treatment with bezafibrate to lower cholesterol curbs the incidence and delays the onset of type 2 diabetes in obese individuals, doctors in Israel report.

In comments to Reuters Health, sudy leader Dr. Alexander Tenenbaum from Chaim Sheba Medical Center in Tel-Hashomer noted that obesity has reached "epidemic dimensions worldwide" and is clearly associated with type 2 diabetes and metabolic syndrome -- a cluster of conditions including high blood pressure, high cholesterol and diabetes.

"Our study," he continued, "has shown that bezafibrate can reduce the incidence of type 2 diabetes with a magnitude of benefit even better than other medications -- 41 percent reduction during about 6 years. Moreover, bezafibrate also delayed the onset of diabetes by about 2 years."

"It seems logical," Tenenbaum added, that combining bezafibrate with other drugs, such as statins and metformin, might achieve even better results.

In an earlier study, the researchers observed that bezafibrate reduced the incidence of diabetes in patients with impaired fasting glucose levels, a precursor to full-blown diabetes. Theorizing that this effect would also be present in obese individuals with normal fasting glucose levels, the investigators randomized 339 non-diabetic obese patients to 400 milligrams bezafibrate or inactive placebo once daily.

Ninety-eight of the subjects developed diabetes over a median of 6.3 years. Diabetes developed in many more subjects in the placebo arm than in the bezafibrate arm -- 37 percent versus 27 percent, the team reports in the European Heart Journal.

Moreover, the time to onset of diabetes was significantly longer in the bezafibrate group compared with the placebo group -- 4 years versus 2 years. In a model adjusting for numerous other factors, bezafibrate therapy independently lowered the risk of developing diabetes by 41 percent.

Bezafibrate has both lowers harmful triglycerides and raises "good" HDL-cholesterol and also reduces blood sugar levels.

The current study, Tenenbaum told Reuters Health, "reinforces the argument that management of atherogenic dyslipidemia in patients with obesity, metabolic syndrome and/or type 2 diabetes should be focused not just on LDL cholesterol, but on triglycerides and HDL cholesterol as well."

SOURCE: European Heart Journal October, 2005.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDiabetes

Keep reading

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.